NCT04694820View on ClinicalTrials.gov

A Mobile Intervention (txt4TKI) for the Improvement of Tyrosine Kinase Inhibitor Management in Patients With Chronic Myeloid Leukemia

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 5, 2020

Primary Completion Date

April 8, 2022

Study Completion Date

April 8, 2022

Conditions
Chronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Phase Chronic Myelogenous Leukemia
Interventions
OTHER

Text Message-Based Navigation Intervention

Receive txt4TKI

OTHER

Survey Administration

Ancillary studies

Trial Locations (1)

19107

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia

All Listed Sponsors
lead

Thomas Jefferson University

OTHER

NCT04694820 - A Mobile Intervention (txt4TKI) for the Improvement of Tyrosine Kinase Inhibitor Management in Patients With Chronic Myeloid Leukemia | Biotech Hunter | Biotech Hunter